P301L tauopathyconfocal immunofluorescence study of perinuclear aggregation of the mutated protein

Journal of the Neurological Sciences

Volumn 200, Issue 1-2, 2002, Pages 85-93

  Adamec, Emil ^a   Murrell, Jill R ^b   Takao, Masaki ^b   Hobbs, Wendy ^c   Nixon, Ralph A ^d   Ghetti, Bernardino ^b   Vonsattel, Jean P ^e  

^a MCLEAN HOSPITAL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Confocal microscopy; Frontotemporal dementia; Immunohistochemistry; Mutation; Tau protein; Tauopathy

Indexed keywords

MUTANT PROTEIN; TAU PROTEIN;

ARTICLE; CONFOCAL MICROSCOPY; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NERVE DEGENERATION; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; AGED; AMINO ACID SUBSTITUTION; BRAIN; CELL AGGREGATION; CELL NUCLEUS; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; METHODOLOGY; MUTATION; PATHOLOGY; TAUOPATHY;

AGED; AMINO ACID SUBSTITUTION; BRAIN; CELL AGGREGATION; CELL NUCLEUS; FEMALE; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUTATION; TAU PROTEINS; TAUOPATHIES;

EID: 0037101812     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00150-8     Document Type: Article

References (50)

1. Frontal lobe degeneration of non-Alzheimer type: II. Clinical picture and differential diagnosis
2. Dementia of frontal lobe type
3. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies
4. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22
5. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference
6. Phenotypic correlations in FTDP-17
7. The molecular genetics of the tauopathies
8. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
9. Tau is a candidate gene for chromosome 17 frontotemporal dementia
10. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
11. Tau mutations cause frontotemporal dementias
12. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family
13. Structure and novel exons of the human tau gene
14. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
15. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
16. Untangling tau-related dementia
17. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
18. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
19. A P301L tauopathy with argyrophilic, tau-positive, perinuclear rings
20. An improved approach to prepare human brains for research
21. Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers
22. Nuclear staining for laser confocal microscopy
23. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease
24. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes
25. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
26. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
27. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
28. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau
29. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
30. Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients
31. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease
32. Tau pathology in a family with dementia and a P301L mutation in tau
33. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
34. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
35. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
36. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
37. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
38. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation
39. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes
40. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain
41. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease
42. Calcium-activated neutral proteinase calpain system in aging and Alzheimer disease
43. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
44. Neurotoxicity induces cleavage of p35 to p25 by calpain
45. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
46. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau
47. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion
48. Ubiquitin-mediated proteolysis: biological regulation via destruction
49. The proteasome, a novel protease regulated by multiple mechanisms
50. The 26S proteasome: a molecular machine designed for controlled proteolysis